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ABSTRACT
Introduction: The specialized literature states that anxiety can interfere with cognition, 
particularly in complex cognitive processes such as those related to executive functioning. 
Neuropsychological studies in anxiety disorders have confirmed the presence of 
deficits in executive functions, with significant changes in its components. The main 
aim of this study was to compare the executive performance of a sample with anxiety 
disorder to a control group, using an instrument that differs from the others by high 
ecological validity, revealing a higher predictive evidence on daily tasks.
Methods: This study included 60 participants aged between 18 and 53 years that 
were allocated to an experimental group (n = 30; mean = 31.93; standard deviation 
[SD] = 10.99) and a control group (n = 30; mean = 29.63; SD = 9.07). Anxiety symptoms 
and the executive functioning were assessed using the Beck Anxiety Inventory (BAI) 
and the Behavioural Assessment of the Dysexecutive Syndrome (BADS), respectively.
Results: Participants with anxiety disorders presented a significant impairment on 
executive functioning in general. However, we found a significant impact in tasks that 
involve control inhibition, design of action strategies according to the functionality 
and probability of success, the ability to predict or estimate and the ability to plan the 
action. In addition, the EG required significantly more time to execute all the tests 
(mean = 440.33, SD = 97.17), compared to the CG (mean = 320.90; SD = 51.27).
Conclusions: Individuals with anxiety disorders have a significant impairment in their 
executive functioning in general, which is reflected in activities of daily living.
Keywords: Anxiety disorders; executive functions; BADS; cognitive and affective 
evaluation
Anxiety disorders (AD) are one of the most common mental disorders1,2, 
affecting 33.7% of the population during their lifetime3. Anxiety is a natural and 
perfectly adaptive phenomenon that can be defined as a complex cognitive, 
affective, physiological and behavioral response system which is activated 
when anticipated events or circumstances are deemed to be highly aversive 
because they are perceived to be unpredictable or uncontrollable events that 
could potentially threaten the vital interest of an individual4. However, it is 
the intensity of anxiety that determines the difference between normal and 
pathological states5. Anxiety and fear are recognized to be pathological when 
they are exaggerated, disproportional to the stimulus or qualitatively different 
from what is observed as a norm in that age group and when they interfere 
with the individual’s quality of life, emotional comfort, or daily life performance6.
The importance of anxiety in the cognition field lies on its usual association 
with adverse effects on the performance of cognitive tasks7, with both the 
anxiety state and trait having these effects on complex cognitive tasks8. 
Neuropsychological studies in the literature have demonstrated the presence of 
deficits in executive functioning (EF)9-11, which involves a variety of higher-order 
cognitive processes12,13 that are probably the most complex aspect of human 
cognition14. Most authors considered that EF does not correspond to a unique 
cognitive ability, but rather to a set of competencies15,16 related to production, 
supervision and behavioral control. These competencies work for specific 
objectives17,18 involving operational memory, selective attention, planning and 
problem solving, cognitive flexibility, inhibition control, and decision-making19. 
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EF includes the ability to initiate actions, plan and 
predict ways to solve problems, bring consequences 
and modify strategies in a flexible way, with frontal 
lobes being essential for these processes19, particularly 
the prefrontal cortex (PFC)20. However, according 
to the specialized literature, anxiety is linked to 
the amygdala and to PFC dorsal and ventromedial 
areas21. There is an increase in amygdala activation 
and a decrease in activity in the left and right PFC, 
which is related to deficits in the emotional system22. 
At the neurobiological level, anxiety allows a quick 
detection and response to the threat, which is 
an evolutionarily significant aspect of automatic 
self-regulation. However, high levels of fear may 
lead to a biased processing toward limbic centers 
in order to facilitate faster behavioral responses, a 
process that may inhibit prefrontal cortical function23. 
When anxiety is excessive, attention may be altered, 
making it difficult to plan and execute long-term 
goals and increasing the performance of behaviors 
guided by immediate goals24. Recently, the study of 
Park et al.25 endorsed this observation, suggesting 
that anxiety seems to be associated with PFC 
hipoactivity by disrupting its activity and suppressing 
the spontaneous activity of PFC neurons, which could 
create executive deficits.
Given these important evolutionary and neurobiological 
connections between anxiety and EF, several studies 
were interested in analyzing the influence of anxiety 
on the performance of many cognitive tasks, including 
those specific to executive functioning, such as 
task switching, inhibition, problem solving, spatial 
recognition and memory work, motor initiation and 
execution task9-11 and all of these studies confirmed 
that anxiety was significantly predictive of worse 
executive performance. Likewise, a population-based 
study with individuals from 20 to 64 years was in 
agreement with the previous studies, pointing out the 
existence of deficits in EF in general AD26. To explain 
this phenomenon, other researchers proposed that 
the relationship between anxiety and EF reflects a 
tendency to divert attention away from the focus of 
the task toward anxiety-inducing stimuli (e.g. worrying 
thoughts) while in a state of anxiety7.
Although empirical evidence reveals deficits 
in EF in individuals with AD, we found that the 
neuropsychological instruments commonly used in 
studies of this nature have low ecological validity, that 
is, they have an excessively artificial and structured 
nature, not reflecting properly real-life requirements, 
where dysfunctions are felt27. We know that the 
characterization and measurement of changes at 
the executive level constitutes a major challenge to 
modern neuropsychology28. However, the Behavioural 
Assesssment of the Dysexecutive Syndrome (BADS) 
combines a solid theoretical basis with adequate 
psychometric bases for EF evaluation29. This battery of 
neuropsychological tests is recognized as a sensitive 
measure to deficits associated with prefrontal lobe 
dysfunction30,31 and has been used in many contexts 
such as schizophrenia32, attention deficit hyperactivity 
disorder33, recurrent criminal behavior34, depressed 
and suicidal patients35,36, and addictive behaviors37. 
In all these studies, BADS has demonstrated good 
predictive accuracy in the evaluation of EF.
This research aimed to assess EF in patients 
with AD, using a neuropsychological battery with 
high ecological validity, and analyze whether there 
is a variation between executive performance and 
the severity of anxiety symptoms.
METHODS
The sample was composed of 60 participants 
aged between 18 and 53 years, of both genders, 
allocated in two groups, the experimental group 
(EG) and the control group (CG). The EG included 
30 participants with AD, aged between 19 and 53 years 
(mean = 31.93, standard deviation [SD] = 10.99). 
Sample selection was applied an inclusion criteria, 
through the application of the Beck Anxiety Inventory 
(BAI) (with a cut-off point of 7, according to the 
Portuguese normative values) and the exclusion 
criteria were pharmacological and/or psychotherapeutic 
treatments before neuropsychological assessment; 
comorbid psychiatric diseases, e.g. depression, 
attention-deficit hyperactivity disorder; physical, 
mental or sensory impairment; history of neurologic 
disease; consumption of alcohol and/or drugs. 
The CG included 30 healthy participants, aged between 
18 and 49 years (mean = 29.63, SD = 9.07), and 
excluded those with history or presence of anxiety 
and/or depression; other psychiatric or neurological 
diseases; physical, mental or sensory impairment; 
consumption of alcohol and/or drugs.
The sample was recruited from the student support 
department at the psychology consulting service of 
Instituto Universitário de Ciências da Saúde (IUCS). 
The EG was composed of outpatients who sought for 
psychology consultation and presented higher BAI 
scores than the cut-off point. The diagnosis of the 
EG was made through a semi-structured interview 
and the DSM-5, to ensure that individuals presented 
criteria compatible with AD. These participants were 
identified before the initiation of the psychological 
intervention.
The CG included students who did not seek 
consultation and obtained lower BAI scores than 
the cut-off point.
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Since there is no evidence of an evaluation of EF 
in AD through the application of the BADS, this is a 
pilot study that aims to investigate whether we can 
find the same results through a neuropsychological 
battery with a higher ecological validity. We are also 
aware that there is a great difficulty to find a significant 
sample of patients with the various types of AD; thus, 
we only collected individuals who had significant 
symptoms in BAI and DSM-5 compatible with AD. 
In addition, patients who search for psychology 
consultation usually require immediate psychotherapy 
and psychopharmacologic intervention to control the 
symptoms; and, according to the literature, these 
factors would interfere with the neuropsychological 
results of our sample. Thus, it was crucial to ensure 
that our sample was as unbiased as possible with 
regard to these variables. In a future study, we would 
like to continue research and investigate the same 
project assumptions in the various types of AD.
The anxiety symptoms were assessed with the 
BAI, created by Beck et al.38. This instrument includes 
21 items that reflect somatic, emotional and cognitive 
characteristics of anxiety38,39, constituting a measure 
that has been carefully designed to avoid confusion 
with depression. BAI items present an accuracy 
of 0.99 (value corresponding to the Cronbach’s alpha) 
and a reliability of 0.79, values that are considered 
adequate. BAI was validated for the Portuguese 
population by Quintão40 and consists in a self-reported 
scale for measuring anxiety intensity, through descriptive 
statements of anxiety rated on a 4-point Likert scale 
(0-3). The score ranges from 0 to 63 and makes it 
possible to classify anxiety into different intensity 
levels, with a higher score representing a higher 
anxiety level38,39. The interpretation of the results 
is based on the following ratings: 0 to 7 - minimum 
anxiety; 8 to 15 - mild anxiety; 16 to 25 - moderate 
anxiety; 26 to 63 - severe anxiety. For the assessment 
of EF the Behavioural Assesssment Dysexecutive 
Syndrome (BADS), developed by Wilson et al.29, was 
administered. It consists of six subtests with activities 
that simulate real life activities designed to diagnose 
the existence of deficits in EF in general or in specific 
components, being sensitive to assess problem 
solving, planning and intentional organization over 
extended periods. The administration of the subtests 
were presented in the following order: Rule Shift Cards 
(to assess the ability to change the set response 
pattern); Action Program (solving a practical problem); 
Key Search (design action strategies according to the 
functionality and probability of success); Temporal 
Judgment (ability to predict or estimate how long it 
takes, on average, to perform various events or day to 
day tasks); Zoo Map (planning action); and Simplified 
Six Elements Test (planning, temporal organization 
of tasks and self-monitoring of the performance). 
BADS is validated for the Portuguese population by 
Barbosa et al.41 and allows the calculation of a profile 
score ranging from 0 to 4 point and a global score 
ranging from 0 to 24 points. The time to execute 
each subtest was recorded, as well as total time to 
execute BADS, contributing for the purpose of listing 
in each of them, except in temporal judgment subtest, 
where there is no time29.
The study protocol was developed in partnership 
with the IUCS, which allowed the patients who did 
the first psychology consultation could be recruited 
to the study. The selection process was properly 
controlled through a semi-structured interview that 
also collected socio-demographic variables such as 
age, socioeconomic level, years of education, all of 
which were matched in both groups.
An informed consent was obtained from all 
participants to ensure that ethical principles related 
of the study objectives, procedures, confidentiality 
and voluntary participation were safeguarded and that 
the objectives of this study did not include invasive 
procedures.
All instruments were administered individually in 
both groups for an average of one hour in a space 
with proper conditions (individual, reserved, clean, 
and free of distractions).
The statistical processing of the data was done 
through the Statistical Package for Social Sciences 
(SPSS) software, version 23. In addition to central 
tendency, dispersion measures (means and standard 
deviations), and frequency distribution for the 
socio-demographic data, a parametric Student t test 
was performed for independent samples to verify the 
differences between the mean values for EG and CG 
with n > 30 for performance of executive functioning. 
A multivariate analysis was also conducted to study 
the effect of anxiety level in the dependent measures 
obtained (BADS total time and score) reporting a 
significant level of p ≤ 0.05. When necessary, multiple 
comparison were made through post-hoc analysis 
with the Holm-Sidak test, because it presents greater 
robustness than the Tukey or Bonferroni tests and 
has been recommended as the first-time procedure 
for multiple comparison42.
RESULTS
The results obtained can be observed through the 
analysis of global scores (Figure 1) and through a 
split analysis for each BADS subtest (Tables 1 and 2), 
regarding the score and time of execution of both 
groups. In Figure 1, on the left, we present central 
and dispersion tendency measures with mean 
values and standard deviations with respect to 
the overall results of executive performance for 
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Figure 1: Means and SE of the total BADS score (on the left) and total BADS execution time, in seconds (on the right) 
obtained by the experimental and control groups in the BADS. Caption: BADS = Behavioural Assessment of the 
Dysexecutive Syndrome; SE = standard error.
both groups. Overall scores obtained by the EG 
(mean = 15.73; SD = 2.68) were clearly lower than 
those of the CG (mean = 20.07; SD = 2.38), with 
a highly significant difference between the groups 
(t(58) = -6.63, p < 0.001). On the right side of the same 
figure, we also show the total time (in seconds) 
required to execute the BADS. It was found that the 
time spent to perform the test presented a statistically 
significant difference (t(58) = 5.95, p < 0.001) between 
the CG (mean = 320.90, SD = 51.26) and the EG 
(mean = 440.33, SD = 97.17). In addition to the 
above-mentioned results, a detailed analysis of the 
Table 1: Means, SD, t values, p values and 95%CI of the experimental and control groups of the obtained results in 
each BADS subtest.
BADS subtests Experimental group Control group t p 95%CIMean (SD) Mean (SD) LL UL
Rule Shifting Cards 2.83 (0.87) 3.57 (0.50) -3.980 < 0.001 -1.102 -0.365
Action Program 3.93 (0.25) 3.97 (0.18) -0.584 < 0.561 -0.148 0.081
Key Search 1.73 (1.20) 2.80 (1.19) -3.460 < 0.001 -1.684 -0.450
Temporal Judgment 1.37 (0.85) 2.73 (0.69) -6.830 < 0.001 -1.767 -0.966
Zoo Map 2.33 (0.80) 3.30 (0.70) -4.966 < 0.001 -1.356 -0.577
Simplified Six Elements 3.53 (0.68) 3.70 (0.59) -1.008 < 0.317 -0.498 0.164
Caption: BADS = Behavioural Assessment of the Dysexecutive Syndrome; CI = confidence interval; LL = lower limit; SD = standard deviation; 
UL = upper limit.
Table 2: Means, SD, t values, p values and 95%CI of the temporal performance (in seconds) of the experimental and 
control groups in the BADS subtests.
BADS subtests Experimental group Control group t p 95%CIMean (SD) Mean (SD) LL UL
Rule Shifting Cards 43.37 (16.55) 34.00 (4.59) 2.987 < 0.004 3.090 15.644
Action Program 99.57 (42.51) 55.03 (20.07) 5.189 < 0.001 27.354 61.713
Key Search 44.30 (19.06) 27.93 (5.37) 4.527 < 0.001 9.130 23.603
Zoo Map 248.83 (69.29) 203.93 (37.75) 3.117 < 0.003 16.062 73.738
Caption: BADS = Behavioural Assessment of the Dysexecutive Syndrome; CI = confidence interval; LL = lower limit; SD = standard deviation; 
UL = upper limit.
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executive performance of both groups was carried 
out in the BADS subtests. Table 1 shows means 
and standard deviations for the results obtained 
by the two groups in each subtest. The EG have a 
lower score on most subtests, except for the Action 
Program and Modified Six Elements Test. In the 
Rule Shifting Cards subtest, we found that the EG 
(mean = 2.83, SD = 0.87) presented significantly 
lower scores (t(58) = -3.98, p < 0.001) than the CG 
(mean = 3.93, SD = 0.25). Conversely, in the Action 
Program subtest, the EG (mean = 3.93, SD = 0.25) 
showed no significant difference (t(58) = -0.584, p < 0.561) 
with the CG (mean = 3.97, SD = 0.18). In the Search Key 
subtest, the EG (mean = 1.73, SD = 1.20) presented a 
statically significant difference (t(58) = -3.460, p < 0.001) 
compared to the CG (mean = 2.80, SD = 1.19). Likewise, 
a statistically significant difference (t(58) = -6.830, p < 0.001) 
was found in the Temporal Judgment subtest 
between the EG (mean = 1.37, SD = 0.85) and the 
CG (mean = 2.73, SD = 0.69). The same was found 
in the Zoo Map subtest (t(58) = -4.966, p < 0.001), 
with mean of 2.33 and SD of 0.80 for the EG and 
mean of 3.30 and SD of 0.70 for the CG. Finally, in 
the Modified Six Elements Test subtest, there were 
no differences (t(58) = -1.008, p < 0.317) between 
the EG (mean = 3.53, SD = 0.68) and the CG 
(mean = 3.70, SD = 0.59).
Table 2 also shows the mean values and standard 
deviations related to the time required for the execution 
of BADS subtests 1, 2, 3 and 5 in seconds. It was 
verified that the temporal performance obtained by 
the EG was significantly different from that of the 
CG in all subtests. The EG (mean = 43.37, SD = 16.55) 
required significantly more time than the CG 
(mean = 34.00, SD = 4.59) to execute the Rule Shifting 
Cards subtest (t(58) = 2.987, p < 0.004). The same was found 
in the Action Program subtest (t(58) = 5.189, p < 0.001), 
with mean of 99.57 and SD of 42.51 for the EG and 
mean of 55.03 and SD of 20.07 for the CG. In the 
Key Search subtest, statistically significant differences 
(t(58) = 4.527, p < 0.001) were observed between 
the EG (mean = 44.30, SD = 19.06) and the CG 
(mean = 27.93, SD = 5.37). Finally, in the Zoo Map 
subtest, the EG (mean = 248.83, SD = 69.29) presented a 
significantly longer execution time (t(58) = 3.117, p < 0.003) 
than the CG (mean = 203.93, SD = 37.75).
The aim of this study was also to make a 
description of EF in the groups according to the 
level of self-reported anxiety state assessed by 
BAI scale (Figure 2). For this purpose, the EG was 
distributed according to the severity of the anxious 
symptoms into three groups: mild anxiety group 
(n = 5), moderate anxiety group (n = 3), and severe 
anxiety group (n = 22). The CG scores were defined 
as absence of anxiety, which was used as a fourth 
group in the analysis.
Through Post-hoc analysis using Holm-Sidak test, 
we found that BADS scores are significantly lower in 
the group with severe anxiety (t(58) = -5.02, p ≤ 0.001) 
compared to the group with no anxiety. No significant 
differences were found in the remaining comparisons 
(absence vs. mild anxiety vs. moderate anxiety). 
The total time to execute BADS was significantly 
higher in individuals with severe anxiety compared to 
those without anxiety (t(58) = 146.87, p ≤ 0.001); and 
in individuals with severe anxiety condition compared 
to those with mild anxiety (t(58) = 126.94, p ≤ 0.004).
Figure 2: Mean values and standard errors for the EG and the CG relatively to the total BADS score (on the left) and total 
time to execute the BADS (in seconds) according to the level of anxiety verified in the BAI. Caption: BADS = Behavioural 
Assessment of the Dysexecutive Syndrome; BAI = Beck Anxiety Inventory; CG = control group; EG = experimental group.
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DISCUSSION
The main aim of this study was to compare EF 
between a sample with AD and a healthy group, 
through a neuropsychological instrument with a 
higher ecological validity than the conventional 
tests31. The other aim was to investigate whether 
there was a variation in BADS performance 
according to the severity of anxious symptoms.
Our results matched the initial expectations 
and were consistent with the results obtained in 
the study by Airaksinen et al.26, which stated that 
individuals with AD present significant general EF 
deficits. The EG exhibited a significantly worse 
performance than the CG and required significantly 
more time to execute the BADS. This lower 
performance shows that individuals with AD have 
a reduced capacity for mental flexibility, reduced 
capacity to plan efficient strategies and to monitor 
and solve problems, reduced judgment capacity 
and abstract thinking, as well as difficulties in 
organizing and monitoring behavior43. Furthermore, 
results for the time of BADS execution were 
consistent with our expectations. It was found that 
individuals with AD required a longer response 
time, with no exception. These findings are in 
agreement with those by Derakshan et al.11, who 
found that individuals with high levels of anxiety 
state had longer response times in complex tasks. 
Total BADS score allows for the assessment of 
general executive performance, whereas BADS 
subtest scores reveal individual performance in 
the different dimensions of EF. Thus, contrary 
to expected results, the EG exhibited deficits 
in executive performance in most, but not all 
measures of the executive component. The results 
for BADS subtests indicate significant impairments 
in the subtests related to: capacity to change 
the previously established standard response, 
corresponding to an inhibition control impairment, 
as tested by others studies with the classic Stroop 
Test7,44,45; the design of action strategies, according 
to the functionality and probability of success; the 
ability to predict or estimate how much time, on 
average, it takes to accomplish certain events; 
and planning action capacity.
However, the skills that required practical 
problem solving seems to be preserved, contrary to 
the study of Joiner et al.46, as well as the capacity 
for temporal organization and self-monitoring. 
These findings may be explained by the Processing 
Efficiency Theory (TEP)47, which states that anxiety 
impairs the efficiency in performing these abilities 
but not performance effectiveness.
The other aim of the study was to verify whether 
the different levels of anxiety as assessed by the 
BAI presented significant effects on EF. Two recent 
studies48,49 concluded that the executive functioning 
profile varied according to the severity of the 
anxiety level. However, the achieved results do not 
corroborate with previous studies, since significant 
differences regarding BADS scores were observed 
only between the group with severe anxiety group 
and that without anxiety, and differences regarding 
temporal performance were observed only between 
the group with severe anxiety and those without 
anxiety and within mild anxiety.
This fact constituted a limitation in our study, 
which was caused by a small sample in the 
various anxiety levels; therefore, a larger sample 
is necessary to obtain more consistent results 
and generalized conclusions. Another limitation 
refers to the non-differentiation of AD included 
in our sample, since the literature indicates that 
each disorder reflects specific deficits26 associated 
with differentiated brain functions50. Thus, we 
are looking at an upcoming study focused on 
the assessment of executive dysfunction in the 
various diagnostic subcategories using the same 
an ecological neuropsychological battery in order 
to obtain a greater prognosis of EF in daily life 
activities.
We conclude that there is a significant 
impairment in EF in patients with AD, based on 
the understanding of neuropsychological battery 
results with high ecological validity, which allows us 
to infer that these individuals present deficits that 
are reflected in their daily tasks. This research adds 
an important contribution to neuropsychological 
research for a better understanding of the real 
impact of anxiety on EF. With the results achieved, 
we can mention the need to implement therapies 
and rehabilitation programs and therapies in order 
to overcome functioning deficits.
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